Business

Prenetics Reports Record Third Quarter 2025 Results; IM8 on Track for $120M ARR¹ by December 2025, Fastest Supplement Brand Growth in Industry History

Total Revenue Surges 568% YoY to $23.6 million; IM8 Monthly Revenue Hits Record US$9 million in October; Bitcoin Treasury Reaches 387 BTC (~$40M); IM8

articlePrenetics Global LimitedNovember 10, 20255/company/prenetics-global-ltd/news/prenetics-reports-record-third-quarter-2025-results-im8-on-track-for-dollar120m-arr-by-december-2025-fastest-supplement-brand-growth-in-industry-history
Prenetics Reports Record Third Quarter 2025 Results; IM8 on Track for $120M ARR¹ by December 2025, Fastest Supplement Brand Growth in Industry History

About this update from Prenetics Global Limited

[{"type":"text","content":"Total Revenue Surges 568% YoY to $23.6 million; IM8 Monthly Revenue Hits Record US$9 million in October; Bitcoin Treasury Reaches 387 BTC (~$40M); IM8 Projects $180 - $200M FY 2026 Revenue, $25M Monthly Revenue or $300M ARR by Year End 2026 IM8 Delivers 60% Gross Margin, 3.9 Months Payback Period, Demonstrating Strong Unit Economics Company to Host Earnings Call Today at 8:30am ET, Releases Inaugural Quarterly Shareholder Letter CHARLOTTE, N.C., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (\"Prenetics\" or the \"Company\"), a leading health sciences company and parent of the IM8 premium health and longevity brand, today announced third quarter 2025 financial results, highlighted by IM8's trajectory towards $120 million in annualized recurring revenue (“ARR”) in just 12 months by December 2025. This unprecedented growth positions IM8 as having the fastest growth trajectory ever recorded in the global supplements industry, outpacing several leading AI startups. The record-breaking performance comes on the heels of Prenetics' successful $44 million equity offering completed in October 2025, which attracted high-quality strategic investors including Kraken, Exodus (NYSE: EXOD), XtalPi (2228.HK), DL Holdings (1709.HK), Jihan Wu's GPTX, and World No. 1 tennis champion Aryna Sabalenka, positioning the Company for accelerated global expansion. IM8: Redefining Industry Growth Standards with Global Reach IM8's extraordinary trajectory reached new heights in October 2025, delivering approximately $9.0 million in monthly revenue – representing 36% month-over-month growth from September's $6.6 million. With this momentum, IM8 is on track to achieve $10 million in monthly revenue by December 2025, translating to a $120 million ARR run rate in just 12 months from launch. The brand has achieved truly global scale with 420,000+ customer purchases across 31 countries worldwide. International markets now represent 56.5% of IM8’s revenue, with the top five markets being: United States (43.5% of revenue)CanadaUnited KingdomAustraliaSingapore In line with our growth trajectory, we are introducing key performance indicators to track and communicate our performance more effectively. IM8 - Key Performance Indicators (Q3 2025 vs Q2 2025, unless otherwise indicated) MetricQ3 2025Q2 2025GrowthMonthly Revenue (End of Period)$6.6...

More updates from Prenetics Global Limited